BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:AN2 Therapeutics\, Inc. (ANTX) investor events
X-WR-CALNAME:AN2 Therapeutics\, Inc. (ANTX) investor events
DESCRIPTION:Earnings calls and investor events for AN2 Therapeutics\, Inc. 
 (ANTX)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for AN2 Therapeutics\, Inc.
  (ANTX)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:a7e29bba-cee5-4577-9120-50016de095cd@equibles.com
DTSTAMP:20260617T191128Z
DTSTART;VALUE=DATE:20251112
DTEND;VALUE=DATE:20251113
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:9a0650ba-6488-47d7-878b-ffde55b5b340@equibles.com
DTSTAMP:20260624T233114Z
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251204
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Conference: 8th Annual Evercore Heal
 thcare Conference
DESCRIPTION:8th Annual Evercore Healthcare Conference\nThe start time has n
 ot been announced.\nWebcast: https://wsw.com/webcast/evercore52/register.a
 spx?conf=evercore52&page=antx&url=https://wsw.com/webcast/evercore52/antx/
 2386582
END:VEVENT
BEGIN:VEVENT
UID:6365f7d3-ba8c-45f1-86ba-7ec4c09524f0@equibles.com
DTSTAMP:20260624T233114Z
DTSTART;VALUE=DATE:20260310
DTEND;VALUE=DATE:20260311
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Conference: Leerink Global Healthcar
 e Conference
DESCRIPTION:Leerink Global Healthcare Conference\nThe start time has not be
 en announced.\nWebcast: https://event.summitcast.com/view/mT9poctHDNthc6b8
 9WqVjf/guest_book?session_id=Tvjzmgvst6rL8gS69cDuiX
END:VEVENT
BEGIN:VEVENT
UID:5d7b6705-7c69-40d5-8f66-c7c683e6df32@equibles.com
DTSTAMP:20260617T191054Z
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260318
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:55535a19-0759-4f0a-a38e-9d59cd24a305@equibles.com
DTSTAMP:20260617T191039Z
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260520
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://invest
 or.an2therapeutics.com/
URL:https://equibles.com/stocks/antx/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:cf83be3d-3fc2-4328-8a01-5b511bc6f582@equibles.com
DTSTAMP:20260624T233114Z
DTSTART;VALUE=DATE:20260604
DTEND;VALUE=DATE:20260605
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Conference: 2026 Jefferies Global He
 althcare Conference
DESCRIPTION:2026 Jefferies Global Healthcare Conference\nThe start time has
  not been announced.\nWebcast: https://event.summitcast.com/view/NgCqua4VV
 Qjq9ibVWHVWca/bXYkeyYHea4WjvcH6haemh
URL:https://equibles.com/stocks/antx/events/cf83be3d-3fc2-4328-8a01-5b511bc
 6f582
END:VEVENT
BEGIN:VEVENT
UID:1ec8abed-cbcc-4415-8142-5bd21d6dcead@equibles.com
DTSTAMP:20261021T002442Z
DTSTART:20261109T143000Z
DTEND:20261109T153000Z
SEQUENCE:25316682
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Conference: Guggenheim 3rd Annual He
 althcare Innovation Conference
DESCRIPTION:Guggenheim 3rd Annual Healthcare Innovation Conference\nWebcast
 : https://investor.an2therapeutics.com/events/event-details/guggenheim-3rd
 -annual-healthcare-innovation-conference
URL:https://equibles.com/stocks/antx/events/1ec8abed-cbcc-4415-8142-5bd21d6
 dcead
END:VEVENT
BEGIN:VEVENT
UID:1b46e22b-a7ca-4f27-87a0-28b30470cd2a@equibles.com
DTSTAMP:20261021T002442Z
DTSTART:20261110T134000Z
DTEND:20261110T144000Z
SEQUENCE:25316682
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Conference: Stifel 2026 Healthcare C
 onference
DESCRIPTION:Stifel 2026 Healthcare Conference\nWebcast: https://investor.an
 2therapeutics.com/events/event-details/stifel-2026-healthcare-conference
URL:https://equibles.com/stocks/antx/events/1b46e22b-a7ca-4f27-87a0-28b3047
 0cd2a
END:VEVENT
BEGIN:VEVENT
UID:b4e4144e-9c74-482d-ad97-5ffacb0c1e32@equibles.com
DTSTAMP:20261021T002442Z
DTSTART;VALUE=DATE:20261117
DTEND;VALUE=DATE:20261118
SEQUENCE:25316682
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:AN2 Therapeutics\, Inc. (ANTX) Conference: Jefferies London Confere
 nce
DESCRIPTION:Jefferies London Conference\nThe start time has not been announ
 ced.\nWebcast: https://investor.an2therapeutics.com/events/event-details/j
 efferies-london-conference
URL:https://equibles.com/stocks/antx/events/b4e4144e-9c74-482d-ad97-5ffacb0
 c1e32
END:VEVENT
END:VCALENDAR